FDA approves ReShape Lifesciences’ next-generation Lap-Band 2.0 FLEX
The FDA has granted approval of a PMA supplement for ReShape Lifesciences’ next generation, enhanced Lap-Band 2.0 FLEX. According to the...
top of page
Browse by category
Search
USGI Medical completes Pilot Study of the POSE2.0 incisionless weight loss procedure
The FDA has acknowledged the successful completion of a pilot study of USGI Medical’s incisionless, endoscopic gastroplasty procedure,...
Skye to develop nimacimab for the treatment of obesity by targeting the endocannabinoid system
Skye Bioscience, a pharmaceutical company developing drugs targeting the endocannabinoid system (ECS), has announced that it plans to...
Levita Magnetics reveals first international deployment of MARS Surgical System
Levita Magnetics announced the international launch of its MARS surgical system at Hospital Luis Tisne in Santiago, Chile. This marks...
Zepbound (tirzepatide) available in US pharmacies for adults living with obesity
Eli Lilly and Company has announced that Zepbound (tirzepatide) injection is now available in US pharmacies for adults with obesity (with...
Roche poised to enter anti-obesity medication market with agreement to acquire Carmot Therapeutics
Roche is poised to enter the lucrative anti-obesity medication market after entering into a definitive merger agreement to acquire Carmot...
Novo Nordisk to initiate study assessing CagriSema vs Tirzepatide
Novo Nordisk is planning a study that will see CagriSema, a new investigational medicine developed by Novo that combines Cagrilintide and...
Fractyl expands ERASE Task Force to study underlying GLP-1-based pancreatic gene therapy for T2DM
Fractyl Health has expanded an academic-industry scientific partnership charged with advancing research on the role of the gut and...
AstraZeneca enters obesity market with $2b deal for GLP-1 candidate
AstraZeneca has signed an exclusive license agreement with Shanghai-based biotech Eccogene for ECC5004, an early-stage investigational...
Lilly's Mounjaro (tirzepatide) receives UK marketing authorisation for weight management
Eli Lilly and Company has granted marketing authorisation (MA) by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for...
Browse by tag
bottom of page